Centers for Disease Control Selects VanishPoint (R) Safety Needle Devices for Anthrax Vaccine Study LITTLE ELM, Texas, May 22, 2002—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that the Centers for Disease Control (CDC) has selected its VanishPoint® automated retraction 3cc syringe and blood

Investrend Research Update on Retractable Technologies: Q1, 2002 Results In-Line With Expectations May 15, 2002–Investrend Research Analyst Justin Canivet issued a research update today on Retractable Technologies (AMEX: RVP), reiterating his strong buy rating. He cited a 12-month price target of $11.00 per share for RVP stock. The full text

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES TWENTY PERCENT REVENUE INCREASE FOR THREE MONTHS ENDED MARCH 31, 2002 LITTLE ELM, Texas, May 9, 2002— Retractable Technologies, Inc. (AMEX: RVP) (“Retractable”) a leading maker of safety needle devices, today reported increased sales for the three months ended March 31, 2002. Net revenues for the

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders LITTLE ELM, Texas – (BW HealthWire) – April 30, 2002 –  Thomas J. Shaw, President and CEO of Retractable Technologies, Inc. (AMEX:RVP – news), a leading maker of safety syringes and blood collection devices, today

Investrend Research Announces Investment Opinion: Retractable Technologies `Strong Buy,’ $11.00 12 Mo Target Issued by Investrend Analyst Justin Canivet, CFA NEW YORK–(BUSINESS WIRE)–April 17, 2002–Investrend analyst Justin Canivet has reiterated a ‘Strong Buy’ and 12 month target of $11.00 on Retractable Technologies (AMEX:RVP). The full report is available at http://www.investrend.com.

Retractable Technologies, Inc. Hires Halliburton Investor Relations to Implement Strategic Financial Communications Program LITTLE ELM, Texas–(BW HealthWire)–April 10, 2002–Retractable Technologies, Inc. (AMEX: RVP – news), a leading manufacturer of safety needle devices, today announced that the company has retained Halliburton Investor Relations (HIR) to develop and implement the company’s strategic

Retractable Technologies, Inc. Announces Significant Revenue Increase for 2001 LITTLE ELM, Texas–(BW HealthWire)–April 3, 2002–Retractable Technologies, Inc. (AMEX:RVP – news; “Retractable’) a leading maker of safety needle devices, today reported record sales for the year ended December 31, 2001. Net revenues for the year ended December 31, 2001 were $16,145,635,

Retractable Technologies, Inc. Receives Contribution From CEO and Spouse Through Royalty Transaction LITTLE ELM, Texas–(BW HealthWire)–Jan. 18, 2002—Retractable Technologies, Inc. (AMEX:RVP – news) a leading maker of safety needle devices, has received a $1 million increase to the shareholders’ equity position by removal of a payable obligation for this same

Britain’s National Health Service Places Retractable Technologies’ Vanishpoint Safety Needle Devices On Supplies List LITTLE ELM, Texas–(BW HealthWire)–Nov. 19, 2001–Retractable Technologies, Inc. (AMEX:RVP), a leading maker of safety needle devices, announced today that Britain’s National Health Service (NHS) Purchasing & Supplies Agency (PASA) has placed Retractable’s VanishPoint(R) line of automated

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RECORD REVENUES FOR THE NINE MONTHS AND FUNDING OF $5 MILLION LITTLE ELM, Texas, November 15, 2001— Retractable Technologies, Inc. (AMEX: RVP) (“Retractable”) a leading maker of safety needle devices, today reported record sales for the nine month period ending September 30, 2001. In addition, the